Skip to main content
Log in

Perioperative management of pancreatic excretory function in the context of pancreatic head resections in PDAC patients

Is the choice of secretion inhibition showing an effect on the rate of clinically relevant fistulas (CR-POPF)?

  • original article
  • Published:
European Surgery Aims and scope Submit manuscript

Summary

Introduction

Postoperative pancreatic fistulas (POPF) are possible origins of dangerous and life-threatening complications after pancreatic head resections. In 2020, a review with over 52,000 patients showed that patients without secretion inhibition (SI) show a higher tendency to develop a POPF. However, there is still no consensus regarding the use of secretion inhibition or in which way it should be administered. The aim of our study is to show whether SI with somatostatin is superior to inhibition with a somatostatin analogue (SA).

Methods

This retrospective data analysis was retrieved from an existing databank. Between 3/2015 and 12/2018, a total of 66 PDAC patients underwent pancreatic head resection. In this group, somatostatin was used as a perioperative secretion inhibitor. The comparison group (n = 91) operated from 1/2010 to 12/2014 received an SA for inhibition. These groups were compared regarding the occurrence of clinically relevant (CR)-POPF.

Results

The frequency rates for biochemical leakage, type B, and type C fistulas in the SA group were 17.58% (n = 16), 30.76% (n = 28), and 9.89% (n = 9), respectively. The somatostatin group showed the following frequencies: 24.2% (n = 16) for biochemical leakage, 16.7% (n = 11) for type B, and 6.1% (n = 4) for type C fistulas. The overall occurrence of CR-POPF was significantly reduced in the somatostatin group (p = 0.0069).

Conclusion

The perioperative use of somatostatin is superior to the use of a somatostatin analogue for POPF prevention in the context of oncological pancreatic head resections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Wang X, Li X, Wei X, Jiang H, Lan C, et al. PD-L1 is a direct target of cancer-FOXP3 in pancreatic ductal adenocarcinoma (PDAC), and combined immunotherapy with antibodies against PD-L1 and CCL5 is effective in the treatment of PDAC. Signal Transduct Target Ther. 2020;5(1):38. https://doi.org/10.1038/s41392-020-0144-8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Christiane J. Bruns. Synopsis—S3 guidelines pancreatic cancer. Chirurg. 2022;93:427–8.

    Google Scholar 

  3. Ouaïssi M, Giger U, Louis G, Sielezneff I, Farges O, et al. Ductal adenocarcinoma of the pancreatic head: a focus on current diagnostic and surgical concepts. World J Gastroenterol. 2012;18(24):3058–69. https://doi.org/10.3748/wjg.v18.i24.3058.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Karunakaran M, Barreto SG. Surgery for pancreatic cancer: current controversies and challenges. Future Oncol. 2021;17(36):5135–62. https://doi.org/10.2217/fon-2021-0533.

    Article  CAS  PubMed  Google Scholar 

  5. Arjunan R, Karthik SDS, Chowdappa R, Althaf S, Srinivas C. Contemporary surgical, oncological, and survival outcomes of pancreaticoduodenectomy for periampullary tumours: a 5-year experience from tertiary cancer center. J Surg Oncol. 2021;12(3):603–10. https://doi.org/10.1007/s13193-021-01385-7.

    Article  Google Scholar 

  6. Bonaroti JW, Zenati MS, Al-Abbas AI, Rieser CJ, et al. Impact of postoperative pancreatic fistula on long-term oncologic outcomes after pancreatic resection. HPB. 2021;23(8):1269–76. https://doi.org/10.1016/j.hpb.2020.12.010.

    Article  PubMed  Google Scholar 

  7. Dhayat SA, Tamim ANJ, Jacob M, Ebeling G, Kerschke L, Kabar I, Senninger N. Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients. PLoS One. 2021;16(6):e0252727. https://doi.org/10.1371/journal.pone.0252727.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Søreide K, Healey AJ, Mole DJ, Parks RW. Pre-, peri- and post-operative factors for the development of pancreatic fistula after pancreatic surgery. HPB. 2019;21(12):1621–31. https://doi.org/10.1016/j.hpb.2019.06.004.

    Article  PubMed  Google Scholar 

  9. Kamarajah SK, Bundred JR, Lin A, Halle-Smith J, Pande R, Sutcliffe R, Harrison EM, Roberts KJ, PARANOIA Study Group. Systematic review and meta-analysis of factors associated with post-operative pancreatic fistula following pancreatoduodenectomy. ANZ J Surg. 2021;91(5):810–21. https://doi.org/10.1111/ans.16408.

    Article  PubMed  Google Scholar 

  10. van Roessel S, Mackay TM, Tol JAMG, van Delden OM, van Lienden KP, et al. Impact of expanding indications on surgical and oncological outcome in 1434 consecutive pancreatoduodenectomies. HPB. 2019;21(7):865–75. https://doi.org/10.1016/j.hpb.2018.10.020.

    Article  PubMed  Google Scholar 

  11. Lichun Sun DHC. Somatostatin and its analogs. Curr Drug Targets. 2016;17(5):529–37. https://doi.org/10.2174/1389450116666141205163548.

    Article  CAS  PubMed  Google Scholar 

  12. Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol. 1999;20(3):157–98. https://doi.org/10.1006/frne.1999.0183.

    Article  CAS  PubMed  Google Scholar 

  13. Reisine T. Somatostatin receptors. Am J Physiol. 1995;269(6 Pt 1):G813–G20. https://doi.org/10.1152/ajpgi.1995.269.6.G813.

    Article  CAS  PubMed  Google Scholar 

  14. Harris AG. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects. Gut. 1994;35(3 Suppl):S1–S4. https://doi.org/10.1136/gut.35.3_suppl.s1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Uhlén M, et al. Tissue-based map of the human proteome. Science. 2015; https://doi.org/10.1126/science.1260419.

    Article  PubMed  Google Scholar 

  16. Leandros E, Antonakis PT, Albanopoulos K, Dervenis C, Konstadoulakis MM. Somatostatin versus octreotide in the treatment of patients with gastrointestinal and pancreatic fistulas. Can J Gastroenterol. 2004;18(5):303–6. https://doi.org/10.1155/2004/901570.

    Article  PubMed  Google Scholar 

  17. Popp FC, Bruns CJ. Range of variation of pancreaticojejunostomy in pancreatic head resection. Chirurg. 2017;88(1):3–10. https://doi.org/10.1007/s00104-016-0327-6.

    Article  CAS  PubMed  Google Scholar 

  18. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, Neoptolemos J, Sarr M, Traverso W, Buchler M, International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.

    Article  PubMed  Google Scholar 

  19. Bassi C, Marchegiani G, Dervenis C, Sarr M, Abu Hilal M, Adham M, Allen P, Andersson R, Asbun HJ, Besselink MG, Conlon K, Del Chiaro M, Falconi M, Fernandez-Cruz L, Fernandez-Del Castillo C, Fingerhut A, Friess H, Gouma DJ, Hackert T, Izbicki J, Lillemoe KD, Neoptolemos JP, Olah A, Schulick R, Shrikhande SV, Takada T, Takaori K, Traverso W, Vollmer CR, Wolfgang CL, Yeo CJ, Salvia R, Buchler M, International Study Group on Pancreatic Surgery (ISGPS). The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After. Surgery. 2017;161:584–91.

    Article  PubMed  Google Scholar 

  20. Berberat PO, Friess H, Büchler MW. The role of octreotide in the prevention of complications following pancreatic resection. Digestion. 1999;60(suppl 2):15–22. https://doi.org/10.1159/000051476.

    Article  CAS  PubMed  Google Scholar 

  21. Katsourakis A, Zezos P, Noussios G, Kouklakis G, Chatzitheoklitos E, Simopoulos K, Pitiakoudis M. Does prophylactic administration of somatostatin decrease the rates of complications after pancreatic resection?: A clinical and electron microscopy study. Pancreas. 2013;42(1):37–41. https://doi.org/10.1097/MPA.0b013e3182557c24.

    Article  CAS  PubMed  Google Scholar 

  22. Callery MP, Pratt WB, Kent TS, et al. A prospectively validated clinical risk score accurately predicts pancreatic fistula after pancreatoduodenectomy. J Am Coll Surg. 2013;216(1):1–14. https://doi.org/10.1016/j.jamcollsurg.2012.09.002.

    Article  PubMed  Google Scholar 

  23. Chen J‑Y, Feng J, Wang X‑Q, Cai S‑W, Dong J‑HY-LC. Risk scoring system and predictor for clinically relevant pancreatic fistula after pancreaticoduodenectomy. World J Gastroenterol. 2015;21(19):5926–33. https://doi.org/10.3748/wjg.v21.i19.5926.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Li Y, Zhou F, Zhu D‑M, Zhang Z‑X, Yang J, Yao J, Wei Y‑J, Xu Y‑L, Dei-Chun LJZ. Novel risk scoring system for prediction of pancreatic fistula after pancreaticoduodenectomy. World J Gastroenterol. 2019;25(21):2650–64. https://doi.org/10.3748/wjg.v25.i21.2650.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Schuh F, Mihaljevic AL, Probst P, et al. A simple classification of pancreatic duct size and texture predicts postoperative pancreatic fistula: a classification of the international study group of pancreatic surgery (ISGPS). Ann Surg. 2021; https://doi.org/10.1097/SLA.0000000000004855.

    Article  PubMed  Google Scholar 

  26. Bertens KA, Crown A, Clanton J, et al. What is a better predictor of clinically relevant postoperative pancreatic fistula (CR-POPF) following pancreaticoduodenectomy (PD): postoperative day one drain amylase (POD1DA) or the fistula risk score (FRS)? HPB. 2017;19(1):75–81. https://doi.org/10.1016/j.hpb.2016.10.001.

    Article  PubMed  Google Scholar 

  27. Jiang L, Ning D, Xiaoping C. Prevention and treatment of pancreatic fistula after pancreatic body and tail resection: current status and future directions. Front Med. 2020;14(3):251–61. https://doi.org/10.1007/s11684-019-0727-3.

    Article  PubMed  Google Scholar 

  28. Liu P, Yang Q, Zhu L. The effects of different treatments on postoperative pancreatic fistula (POPF). J Investig Surg. 2020;33(5):491–2. https://doi.org/10.1080/08941939.2018.1529840.

    Article  Google Scholar 

  29. Hank T, Sandini M, Ferrone CR, et al. Association between pancreatic fistula and long-term survival in the era of neoadjuvant chemotherapy. JAMA Surg. 2019;154(10):943–51. https://doi.org/10.1001/jamasurg.2019.2272.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Birnbaum DJ, Bertucci F, Finetti P, Birnbaum D, Mamessier E. Head and body/tail pancreatic carcinomas are not the same tumors. Cancers. 2019;11(4):497. https://doi.org/10.3390/cancers11040497.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Sülberg D, Chromik AM, Köster O, Uhl W. Prävention und Management von postoperativen Komplikationen in der Pankreaschirurgie. Prevention and Management of Postoperative Complications in Pancreatic Surgery. Zentralbl Chir. 2010;135(2):129–38. https://doi.org/10.1055/s-0030-1247317.

    Article  PubMed  Google Scholar 

  32. Mischinger HJ, Werkgartner G, Kornprat P, Marsoner K, Wagner D, Cerwenka H, Bacher H. Komplikationen in der Pankreaschirurgie. Wien Klin Mag. 2018;21:98–107. https://doi.org/10.1007/s00740-018-0226-1.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Siegfried Sauseng MD MBA FEBS.

Ethics declarations

Conflict of interest

S. Sauseng, A. Imamovic, J. Kresic, T. Niernberger, and H. Rabl declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sauseng, S., Imamovic, A., Kresic, J. et al. Perioperative management of pancreatic excretory function in the context of pancreatic head resections in PDAC patients. Eur Surg 54, 301–308 (2022). https://doi.org/10.1007/s10353-022-00779-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10353-022-00779-3

Keywords

Navigation